CA3056368A1 - Compositions, devices, and methods of fibromyalgia sensitivity testing - Google Patents

Compositions, devices, and methods of fibromyalgia sensitivity testing Download PDF

Info

Publication number
CA3056368A1
CA3056368A1 CA3056368A CA3056368A CA3056368A1 CA 3056368 A1 CA3056368 A1 CA 3056368A1 CA 3056368 A CA3056368 A CA 3056368A CA 3056368 A CA3056368 A CA 3056368A CA 3056368 A1 CA3056368 A1 CA 3056368A1
Authority
CA
Canada
Prior art keywords
value
determined
fibromyalgia
average discriminatory
food preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3056368A
Other languages
English (en)
French (fr)
Inventor
Zackary IRANI-COHEN
Elisabeth LADERMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerica Inc
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of CA3056368A1 publication Critical patent/CA3056368A1/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/02Nutritional disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2842Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
CA3056368A 2016-03-15 2017-03-14 Compositions, devices, and methods of fibromyalgia sensitivity testing Pending CA3056368A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662308348P 2016-03-15 2016-03-15
US62/308,348 2016-03-15
PCT/US2017/022349 WO2017160869A1 (en) 2016-03-15 2017-03-14 Compositions, devices, and methods of fibromyalgia sensitivity testing

Publications (1)

Publication Number Publication Date
CA3056368A1 true CA3056368A1 (en) 2017-09-21

Family

ID=59850607

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3056368A Pending CA3056368A1 (en) 2016-03-15 2017-03-14 Compositions, devices, and methods of fibromyalgia sensitivity testing

Country Status (8)

Country Link
US (1) US20190145972A1 (cg-RX-API-DMAC7.html)
EP (1) EP3430403A4 (cg-RX-API-DMAC7.html)
JP (2) JP2019510226A (cg-RX-API-DMAC7.html)
CN (1) CN109073648A (cg-RX-API-DMAC7.html)
AU (1) AU2017235312A1 (cg-RX-API-DMAC7.html)
CA (1) CA3056368A1 (cg-RX-API-DMAC7.html)
MX (1) MX2018011166A (cg-RX-API-DMAC7.html)
WO (1) WO2017160869A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3940380A1 (en) 2014-11-14 2022-01-19 Biomerica Inc. Compositions, devices, and methods of ibs sensitivity testing
EP3430403A4 (en) * 2016-03-15 2019-08-14 Biomerica Inc. COMPOSITIONS, DEVICES AND METHODS FOR TESTING SENSITIVITY IN FIBROMYALGIA
JP6943479B2 (ja) 2016-07-08 2021-09-29 バイオメリカ・インコーポレイテッドBiomerica, Inc. うつ病感受性試験の組成物、デバイスおよび方法
WO2022133467A1 (en) 2020-12-17 2022-06-23 Cummins Inc. Combustion cylinder end face components including thermal barrier coatings

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689569B2 (en) * 2001-08-14 2004-02-10 Immunosciences Lab., Inc. Saliva test for detection of food allergy, candidiasis, microflora imbalance, intestinal barrier dysfunction and humoral immunodeficiencies
GB0310522D0 (en) * 2003-05-08 2003-06-11 Yorktest Lab Ltd Assay panel
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type
CN101166760A (zh) * 2005-02-15 2008-04-23 阿波罗生命科学有限公司 分子及其嵌合分子
DE202006009206U1 (de) * 2006-03-14 2007-03-29 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Testbestecks zur Bestimmung von neuroendokrinen gesundheitlichen Störungen
US20100227340A1 (en) * 2007-09-10 2010-09-09 Immunohealth International, Llc Method of analysis, detection and correction of food intolerance in humans
EP2730662A1 (en) * 2008-11-12 2014-05-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
CN102438468B (zh) * 2009-04-17 2014-06-04 纳塔克制药有限公司 富含低含量植烷酸的ω-3脂肪酸的组合物
GB201002601D0 (en) * 2010-02-16 2010-03-31 Microtest Matrices Ltd Allergen microarray
HUE035000T2 (en) * 2010-09-29 2018-03-28 Uti Lp A method of treating autoimmune disease using biocompatible bioabsorbable nanospheres
CN103327992B (zh) * 2010-12-03 2016-10-12 信一制药株式会社 用于预防或治疗炎性疾病的包含络石藤提取物和牡丹皮提取物的药物组合物以及制备该药物组合物的方法
GB2490652A (en) * 2011-04-18 2012-11-14 Microtest Matrices Ltd Methods of quantifying antibodies, especially IgE antibodies in a sample
US20130149336A1 (en) * 2011-10-27 2013-06-13 Brian L. Hjelle Methods for Screening Viral Like Particles and Identifying Neutralizing Epitopes and Related Vaccines, Constructs, and Libraries
AU2013216983A1 (en) * 2012-02-07 2014-09-18 La Jolla Institute For Allergy And Immunology Epitopes from allergen proteins and methods and uses for immune response modulation
EP2657707A1 (en) * 2012-04-26 2013-10-30 B.R.A.H.M.S GmbH Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope
JP6285923B2 (ja) * 2012-06-22 2018-02-28 トラスティーズ・オブ・ダートマス・カレッジ 新規VISTA−Igコンストラクト及び自己免疫、アレルギー性及び炎症性障害の処置のためのVISTA−Igの使用
CN202814976U (zh) * 2012-07-31 2013-03-20 白仲虎 一种用于食品不耐受性检测的检测组件
CN110187122A (zh) * 2012-09-05 2019-08-30 亚利桑那州评议委员会,亚利桑那州法人团体,代理和代表亚利桑那州立大学 发现治疗靶标的方法
WO2014066894A1 (en) * 2012-10-26 2014-05-01 Case Western Reserve University Biomarkers for nod2 and/or rip2 activity related application
WO2014182932A1 (en) * 2013-05-08 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Methods of testing for allergen sensitivity
EP3940380A1 (en) * 2014-11-14 2022-01-19 Biomerica Inc. Compositions, devices, and methods of ibs sensitivity testing
EP3430403A4 (en) * 2016-03-15 2019-08-14 Biomerica Inc. COMPOSITIONS, DEVICES AND METHODS FOR TESTING SENSITIVITY IN FIBROMYALGIA

Also Published As

Publication number Publication date
EP3430403A1 (en) 2019-01-23
US20190145972A1 (en) 2019-05-16
WO2017160869A1 (en) 2017-09-21
EP3430403A4 (en) 2019-08-14
CN109073648A (zh) 2018-12-21
MX2018011166A (es) 2019-03-28
JP2019510226A (ja) 2019-04-11
JP2022022426A (ja) 2022-02-03
AU2017235312A1 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
US20230417758A1 (en) Compositions, devices, and methods of ibs sensitivity testing
US12216127B2 (en) Compositions, devices, and methods of depression sensitivity testing
US20190145972A1 (en) Compositions, devices, and methods of fibromyalgia sensitivity testing
US20180364252A1 (en) Compositions, devices, and methods of psoriasis food sensitivity testing
AU2023200262A1 (en) Compositions, devices, and methods of attention deficit disorder/ attention deficit hyperactivity disorder (add/adhd) sensitivity testing
US20190170767A1 (en) Compositions, devices, and methods of ulcerative colitis sensitivity testing
US20190242886A1 (en) Compositions, devices, and methods of gastroesophageal reflux disease sensitivity testing
US20190120835A1 (en) Compositions, devices, and methods of functional dyspepsia sensitivity testing
US20190170768A1 (en) Compositions, devices, and methods of crohn's disease sensitivity testing
US20190004039A1 (en) Compositions, devices, and methods of migraine headache food sensitivity testing
US20250389730A1 (en) Compositions, devices, and methods of depression sensitivity testing
AU2017293937A1 (en) Compositions, devices, and methods of depression sensitivity testing
HK40067075A (en) Compositions, devices, and methods of ibs sensitivity testing

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220311

EEER Examination request

Effective date: 20220311

EEER Examination request

Effective date: 20220311

EEER Examination request

Effective date: 20220311

EEER Examination request

Effective date: 20220311